GenSight Biologics Announces the Availability of a Prospectus in Connection With the Listing of New Shares on Euronext Paris finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
GenSight Biologics Announces the Filing of its 2023 Universal Registration Document streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GenSight Biologics Announces its 2024 Financial Calendar finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Paris, France, April 4, 2024, 7:00 pm CET - GenSight Biologics , a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative.